Do we still need cardiac glycosides?;Werden herzglykoside zur therapie der herzinsuffizienz noch benötigt?

Deutsche Medizinische Wochenschrift

Volumn 127, Issue 41, 2002, Pages 2133-2138

  Bohm M ^a  

^a SAARLAND UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CAPTOPRIL; CARDIAC GLYCOSIDE; DIGITALIS GLYCOSIDE; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; DOBUTAMINE; ENALAPRIL; MILRINONE; PLACEBO; RAMIPRIL; XAMOTEROL;

CARDIOVASCULAR DISEASE; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; HEART FAILURE; HUMAN; MAJOR CLINICAL STUDY; META ANALYSIS; MULTICENTER STUDY; RANDOMIZED CONTROLLED TRIAL; REVIEW; TREATMENT INDICATION; TREATMENT OUTCOME;

CARDIAC GLYCOSIDES; CARDIOTONIC AGENTS; CLINICAL TRIALS; DIGOXIN; DOBUTAMINE; HEART FAILURE, CONGESTIVE; HUMANS; MULTICENTER STUDIES; ODDS RATIO; RISK; SEVERITY OF ILLNESS INDEX; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 0037064160     PISSN: 00120472     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2002-34645     Document Type: Review

References (39)

1. Böhm M, Erdmann E. Therapie der chronischen herzinsuffizienz. Springer Verlag Heidelberg, In: Klinische Kardiologie, Erdmann E (Hrsg.). 2000: 612-700.
2. Braunwald E. Effects of digitalis on the normal and the failing heart. J Am Coll Cardiol 1985; 5: 51A-59A
3. Christian HA. Digitalis effects in chronic cardiac cases with regular rhythm in contrast to auricular fibrillation. Med Clin North Am 1922; 5: 1173-1190
4. Cohn JN, Levine TB, Olivari MT, Gerberg V, Lura D, Francis GS, Simon AB, Rector T. Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N Engl J Med 1984; 311: 819-823
5. DiBianco R, Shabetai R, Kostuk W, Moran J, Schlant RC, Wright R for the Milrinone Multicenter Trial Group. Oral milrinone and digoxin in heart failure: Results of a placebo controlled prospective trial of each agent and the combination. N Engl J Med 1989; 320: 677-683
6. Feldman MD, Alderman JD, Aroesty JM, Royal HD, Ferguson JJ, Owen RM, Grossman W, McKay RG. Depression of systolic and diastolic myocardial reserve during atrial pacing tachycardia in patients with dilated cardiomyopathy. J Clin Invest 1988; 82: 1661-1669
7. Fleg JL, Gottlieb SH, Lakatta EG. Is digoxin really important in treatment of compensated heart failure? A placebo-controlled crossover study in patients with sinus rhythm. Am J Med 1982; 73: 244-250
8. Fleg JL, Rothfeld B, Gottlieb SH. Effect of maintenance digoxin therapy on aerobic perfomance and exercise left ventricular function in mild to moderate heart failure due to coronary artery disease: A randomized, placebo-controlled, cross-over trial. J Am Coll Cardiol 1991; 17: 743-751
9. Ferguson DW, Berg WJ, Sanders JS. Clinical and hemodynamic correlates of sympathetic nerve activity in normal humans and patients with heart failure. Evidence from direct microneurographic recordings. J Am Coll Cardiol 1990; 82: 1724-1729
10. Ferguson DW, Berg WJ, Sanders JS et al. Sympathoinhibitory responses to digitalis glycosides in heart failure patients. Direct evidence from sympathetic neural recordings. Circulation 1989; 80: 65-70
11. Gheorghiade M, Hall V, Lakier BJ, Goldstein S. Comparative hemodynamic and neurohormonal effects of intravenous captopril and digoxin and their combinations in patients with severe heart failure. J Am Coll Cardiol 1989; 13: 134-142
12. Gheorghiade M, St Clair J, St Clair C, Beller G. Hemodynamic effects of intravenous digoxin in patients with severe heart failure initially treated with diuretics and vasodilators. J Am Coll Cardiol 1989; 9: 949-957
13. German and Austrian Xamoterol Study Group. Double-blind placebo-controlled comparison of digoxin and xamoterol in chronic heart failure. Lancet 1988; 1: 488-492
14. Guyatt GH, Sullivan MJJ, Fallen EL et al. A controlled trial of digoxin in congestive heart failure. Am J Cardiol 1988; 61: 371-375
15. Higgins CB, Vatner SF, Eckberg DL, Braunwald EG. Alterations in the baroreceptor reflex in conscious dogs with heart failure. J Clin Invest 1972; 51: 715-224
16. Hirsch AT, Dzau VJ, Creager MA. Baroreceptor function in congestive heart failure: Effect on neurohumoral activation and regional vascular resistance. Circulation 1987; 75: IV36-IV48
17. Iesaka Y, Aonuma K, Gosselin AJ et al. Susceptibility of infracted canine hearts of digitalis-toxic ventricular tachycardia. J Am Coll Cardiol 1983; 2: 45-51
18. Lee DC-S, Johnson RA, Bingham JB et al. Heart failure in outpatients: A randomized trial of digoxin versus placebo. N Engl J Med 1982; 306: 699-705
19. Lindsay SJ, Keamey MT, Prescott RJ, Fox KAA, Nolan J for the UK Heart Investigation. Digoxin and mortality in chronic heart failure. The Lancet 1999; 354: 1003
20. Luten D. Clinical studies of digitalis: Effects produced by administration of massive dosage to patients with normal mechanism. Arch Inter Med 1924; 33: 251-278
21. McClements BM, Adgey AAJ. Value of signal-averaged electrocardiolography, radionuclide ventriculopathy, Holter monitoring and clinical variables for prediction of arrhythmic events in survivors of acute myocardial infarction in the thrombolytic era. J Am Coll Cardiol 1993; 21: 1419-1427
22. Nolan J, Batin PD, Andrews R et al. Prospective study of heart rate variability and mortality in chronic heart failure; results of the United Kingdom Heart Failure Evaluation and Assessment of Risk Trial (UK-HEART). Circulation 1998; 98: 1510-1516
23. Packer M, Carver JR, Rodeheffer RJ et al. Effect of oral milrinone on mortality in severe chronic heart failure. N Engl J Med 1991; 325: 1468-1475
24. Packer M, Gheorghiade M, Young JB et al. for the RADIANCE-Study. Withdrawal of digoxin from patients with chronic heart failure treated with angiotensin-converting enzyme inhibitors. N Engl J Med 1993; 329: 1-7
25. Ribner HS, Plucinski DA, Hsieh A et al. Acute effects of digoxin on total systemic vascular resistance in congestive heart failure due to dilated cardiomyopathy: A hemodynamic-hormonal study. Am J Cardiol 1985; 56: 896-904
26. Schobel HP, Oren RM, Roach PJ et al. Contrasting effects of digitalis and dobutamine on baroreflex sympathetic control in normal humans. Circulation 1991; 84: 1118-1129
27. Schwinger RHG, Böhm M, Koch A, Schmidt U, Morano I, Eissner HJ, Überfuhr P, Reichart B, Erdmann E. The failing human heart is unable to use the Frank-Starling mechanism. Circ Res 1994; 74: 959-969
28. Schwinger RHG, Böhm M, Müller-Ehmsen J, Uhlmann R, Schmidt IJ, Stäblein A, Überfuhr P, Kreuzer E, Reichart B, Eissner HJ, Erdmann E. Effect of inotropic stimulation on the negative force-frequency-relationship in the failing human heart. Circulation 1993; 88: 2267-2276
29. Spargias SK, Hall SA, Ball GS. Safety concerns about digoxin after acute myocardial infarction. The Lancet 1999; 354: 391-392
30. Taggart AJ, Johnston GD, McDevitt DG. Digoxin withdrawal after cardiac failure in patients with sinus rhythm. J Cardiovasc Phamacol 1983; 5: 229-234
31. Thames MD, Waickman LA, Abboud FM. Sensitization of cardiac receptors (vagal afferents) by intracoronary acetylstrophanthidin. Am J Phyiol 1980; 239: H628-H635
32. The AIRE study investigators. Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. Lancet 1993; 343: 821-828
33. The Captopril-Digoxin Multicenter Research Group. Comparative effects of Captopril and digoxin in patients with mild to moderate heart failure. JAMA 1988; 259: 539-555
34. The Consensus Trial Study Group. Effects of enalapril on mortality in severe congestive heart failure: Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). N Engl J Med 1987; 316: 1429-1435
35. The Digitalis Investigation Group (DIG). The effect of digoxin on mortality and morbidity in patients with heart failure. N Engl J Med 1997; 336: 525-533
36. Uretsky BF, Young JB, Shadidi FE et al. on behalf of the PROVED Investigative Group. Randomized study assessing the effect of digoxin withdrawal in patients with mild to moderate chronic congestive heart failure: Results of the PROVED trial. J Am Coll Cardiol 1993; 22: 955-964
37. Varonkow Y, Shell WE, Smirnov V, Gukovsky D, Chazov EI. Augmentation of serum CPK activity by digitalis in patients with acute myocardial infarction. Circulation 1977; 55: 719-727
38. Withering W. An account of the foxglove and some if its medical uses, with practical remarks on dropsy and other diseases. New York, NY, Schuman, In Willins FAa, Keyes TE (ed): Classics of Cardiology. 1941: 231-252
39. Zucker IH, Peterson TV, Gilmore JP. Ouabain increases left atrial stretch receptor discharge in the dog. J Pharmacol Exp Therap 1980; 212: 320-324